These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6147937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Reserpine and breast cancer].
    Böttiger LE.
    Lakartidningen; 1974 Nov 13; 71(46):4607-8. PubMed ID: 4427494
    [No Abstract] [Full Text] [Related]

  • 3. Reserpine and breast cancer.
    Kewitz H, Jesdinsky HJ, Kreutz G, Schulz R.
    Arch Int Pharmacodyn Ther; 1980 Nov 13; Suppl():22-4. PubMed ID: 7416876
    [No Abstract] [Full Text] [Related]

  • 4. [Is there a basis for the suggested significance of rauwolfia preparations in the development of breast cancer?].
    Tikhonova NA, Lazarev NI, Samoĭlenko LA.
    Klin Med (Mosk); 1979 May 13; 57(5):52-6. PubMed ID: 480869
    [No Abstract] [Full Text] [Related]

  • 5. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women.
    Ross RK, Paganini-Hill A, Krailo MD, Gerkins VR, Henderson BE, Pike MC.
    Cancer Res; 1984 Jul 13; 44(7):3106-8. PubMed ID: 6722826
    [Abstract] [Full Text] [Related]

  • 6. [Rauwolfia preparations and breast cancer].
    Ugeskr Laeger; 1974 Nov 04; 136(45):2536. PubMed ID: 4425388
    [No Abstract] [Full Text] [Related]

  • 7. [Hormones and breast cancer. Current views].
    Molinatti GM, Limone P.
    Minerva Med; 1982 Apr 21; 73(17):1047-53. PubMed ID: 6281687
    [No Abstract] [Full Text] [Related]

  • 8. The hypertensive patient.
    Feferman I.
    Can Med Assoc J; 1980 Feb 09; 122(3):270, 273. PubMed ID: 7370820
    [No Abstract] [Full Text] [Related]

  • 9. Reserpine: the maligned antihypertensive drug.
    Widmer RB.
    J Fam Pract; 1985 Jan 09; 20(1):81-3. PubMed ID: 3965606
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Editorial: Reserpine and breast cancer: a perspective.
    Jick H.
    JAMA; 1975 Aug 25; 233(8):896-7. PubMed ID: 1173902
    [No Abstract] [Full Text] [Related]

  • 13. [Genesis of breast cancer: a multifactorial etiology].
    Caffier H.
    Med Klin; 1980 Sep 26; 75(20):713-20. PubMed ID: 6252427
    [No Abstract] [Full Text] [Related]

  • 14. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH, Miller KK, Schuler LA.
    J Steroid Biochem Mol Biol; 2004 Jan 26; 88(1):69-77. PubMed ID: 15026085
    [Abstract] [Full Text] [Related]

  • 15. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL, Katzenellenbogen BS.
    Cancer Res; 1982 Jan 26; 42(1):139-44. PubMed ID: 7053842
    [No Abstract] [Full Text] [Related]

  • 16. [Breast cancer-estrogens relationship].
    Angelescu N.
    Chirurgia (Bucur); 2001 Jan 26; 96(4):335-9. PubMed ID: 12731198
    [Abstract] [Full Text] [Related]

  • 17. Editorial: Rauwolfia derivatives and breast cancer.
    Med J Aust; 1974 Nov 16; 2(20):722. PubMed ID: 4444628
    [No Abstract] [Full Text] [Related]

  • 18. Proceedings: Hypotheses regarding the etiology of breast cancer.
    Cole P.
    Proc Natl Cancer Conf; 1972 Nov 16; 7():657-61. PubMed ID: 4587660
    [No Abstract] [Full Text] [Related]

  • 19. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
    Lunenfeld B, Geier A.
    Isr J Med Sci; 1981 Nov 16; 17(9-10):954-9. PubMed ID: 7031015
    [Abstract] [Full Text] [Related]

  • 20. Letter: Reserpine, prolactin, allergy, and breast cancer.
    Skutsch GM.
    Lancet; 1974 Oct 19; 2(7886):967. PubMed ID: 4138383
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.